มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo sa ograniČenom odgovornoŠĆu "medical solutions" - in vitro dijagnostička medicinska sredstva

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

beckman coulter ,inc. s. kraemer blvd.250 92821 brea sad -

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - medicinska sredstva za višekratnu upotrebu

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"adoc" beograd predstavniŠtvo budva - in vitro dijagnostička medicinska sredstva

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pfizer bh d.o.o. sarajevo - moroktokog alfa - prašak i rastvarač za rastvor za injekciju - 250 i.j./1 bočica - 1 bočica sa praškom sadrži: 250 iu moroktokog alfa (rekombinantni koagulacijski faktor viii)

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pfizer bh d.o.o. sarajevo - moroktokog alfa - prašak i rastvarač za rastvor za injekciju - 500 i.j./1 bočica - 1 bočica sa praškom sadrži: 500 iu moroktokog alfa (rekombinantni koagulacijski faktor viii)

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pfizer bh d.o.o. sarajevo - moroktokog alfa - prašak i rastvarač za rastvor za injekciju - 1000 i.j./1 bočica - 1 bočica sa praškom sadrži: 1000 iu moroktokog alfa (rekombinantni koagulacijski faktor viii)

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastična sredstva - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.